NVC-422

· NovaBay Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NVC-422, covering 2011-09-12 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis [Phase 2]